Celldex Therapeutics, Inc. (CLDX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated…
Source: Yahoo Finance
Sector & Industry
Celldex Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Celldex Therapeutics, Inc. at a Glance
| Company | Celldex Therapeutics, Inc. |
| Ticker | CLDX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $39.68 |
| Market cap | $3.12B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$4.35 |
| 52-week high | $45.14 |
| 52-week low | $22.10 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.84 |
| Return on equity (ROE) | -43.88% |
| Debt-to-equity | 0.69% |
| Average volume | 996,677 |
| Shares outstanding | 78.53M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 198 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Celldex Therapeutics, Inc.'s current P/E ratio?
- Celldex Therapeutics, Inc. (CLDX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Celldex Therapeutics, Inc.'s market capitalisation?
- Celldex Therapeutics, Inc.'s market cap is $3.12B based on our latest snapshot. See how it ranks by market cap →
- What is CLDX's 52-week range?
- Over the past 52 weeks, CLDX has traded between $22.10 and $45.14. What does the 52-week range mean? →
- How volatile is Celldex Therapeutics, Inc. compared to the market?
- Celldex Therapeutics, Inc. has a beta of 0.84, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Celldex Therapeutics, Inc. pay a dividend?
- Celldex Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is CLDX listed on?
- CLDX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Celldex Therapeutics, Inc. in?
- Celldex Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →